Indivior PLCHere is the public summary page for Indivior PLC. Please login to see the complete information for Indivior PLC including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Indivior PLC stacks up relative to its peers. |
| Darwin Score | +32 |
| Ticker | INDV |
| Latest Price | 11.41 GBP as of close on 16-Jul-2025 |
| 3 Month price range | 6.60 to 11.67 GBP |
| Market Capitalisation | 1.44Bn GBP |
| Country | United Great Britain and Northern Ireland |
| Region | Europe |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Pharmaceuticals |
| Sub-Industry | Pharmaceuticals |
| Description | Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia. See More ... |
| Company URL | https://www.indivior.com |
| See Darwins Full Analysis for Indivior PLC |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Indivior PLC. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +29 |
| Sentiment | News and Candle Patterns. | -1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -3 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | +7 |
Alerts
There are 8 live alerts for Indivior PLC.
- Overbought - The 15 week RSI is +77.5. (Negative)
- Overbought - The 5 month RSI is +84.4. (Negative)
- Candle Pattern :: Inverted Hammer (Bearish) (Negative) (Negative)
- Price crossing down through 5 day SMA. This alert has occurred 28 times over the last last year. The average forward returns are 1.3% over 5 days, 3.4% over 10 days, 4.3% over 15 days and 6.5% over 20 days. (Positive)
- Divergence: Px Up & 5d RSI Down last 10 days. This alert has occurred 43 times over the last last year. The average forward returns are 1.6% over 5 days, 2.6% over 10 days, 6.1% over 15 days and 6.4% over 20 days. (Negative)
- Divergence: Px Up & 30d RSI Down last 20 days. This alert has occurred 28 times over the last last year. The average forward returns are 2.4% over 5 days, 1.7% over 10 days, -0.3% over 15 days and -3.4% over 20 days. (Negative)
- Cross Over (Down): 5dma . This alert has occurred 28 times over the last last year. The average forward returns are 1.3% over 5 days, 3.4% over 10 days, 4.3% over 15 days and 6.5% over 20 days. (Negative)
- Divergence: Px Up & 15d RSI Down last 20 days. This alert has occurred 36 times over the last last year. The average forward returns are 2.5% over 5 days, 2.1% over 10 days, 1.5% over 15 days and -1.2% over 20 days. (Negative)
Peer Comparison
There are 4 peers of Indivior PLC.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| AstraZeneca PLC (AZN) | Pharmaceuticals | +11 |
| GSK plc (GSK) | Pharmaceuticals | +23 |
| Hikma Pharmaceuticals PLC (HIK) | Pharmaceuticals | -2 |
| Sareum Holdings PLC (SAR) | Pharmaceuticals | +5 |
Share 
